Latest News

05

November 2018

iX Biopharma will be presenting its Wafermine Phase 2 study results at the Bio-Europe 24th Annual International Partnering Conference...

Read On

27

September 2018

iX Biopharma Ltd. is pleased to announce that it has published its Annual Report FY2018...

Read On

Our Sublingual Technology

Sublingual wafer administration offers the convenience of use over oral delivery, circumventing the drug breakdown in liver or gastrointestinal tract. The technology also provides rapid absorption, achieving maximum desirable therapeutic effect in a non-invasive manner.

Read On

Contact us

iX Biopharma Ltd

1 Kim Seng Promenade
#14-01 Great World City East Tower
Singapore 237994
T: +65 6235 2270
F: +65 6235 2170
E: info@ixbiopharma.com